Yunnan, China

Wei Sun


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (2013 - 2014)
  • Yunnan, CN (2014 - 2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovations of Wei Sun: A Pioneer in Medicinal Chemistry**

Introduction

Wei Sun is an accomplished inventor based in Yunnan, China, with a remarkable portfolio of six patents. His work primarily revolves around the field of medicinal chemistry, focusing on innovative compounds that serve as potential therapeutic options for cancer treatment and other diseases.

Latest Patents

One of Wei Sun's notable recent patents includes the development of Spiro-oxindole MDM2 antagonists. These compounds and compositions are designed to inhibit the interaction between p53 and MDM2, aiming to provide therapeutic benefits in treating various diseases, particularly cancer. This breakthrough illustrates the significant impact of his research in advancing medicinal chemistry.

Career Highlights

Throughout his career, Wei Sun has made substantial contributions to pharmaceutical science, partnering with reputable organizations. Notably, he has worked at the University of Michigan and Sanofi, where he collaborated on groundbreaking research and innovative solutions in drug development.

Collaborations

Wei Sun's work has benefited from collaborations with esteemed colleagues such as Shaomeng Wang and Yujun Zhao. These partnerships have fostered a collaborative environment, enhancing the scope and impact of their collective research efforts.

Conclusion

In conclusion, Wei Sun stands out as a visionary inventor in the realm of medicinal chemistry. His contributions, particularly in the development of Spiro-oxindole MDM2 antagonists, showcase his commitment to innovation and his potential to transform therapeutic approaches to cancer and other serious illnesses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…